AMERSHAM, Engeland, MALVERN, Pa.–(BUSINESS WIRE)– Phlexglobal, pionier in Trial Master File-technologie (TMF) en aanverwante diensten voor de levenswetenschappelijke sector, heeft vandaag de overname van Net Solutions Europe (NSE) bekendgemaakt. NSE is een in het Verenigd Koninkrijk gevestigd technologiebedrijf dat veel successen in de oplevering van softwaresystemen kent.
Phlexglobal werkt al sinds 2010 samen met NSE aan PhlexEview, een toonaangevend elektronisch TMF-platform in de cloud. De overname verstevigt Phlexglobals koppositie in de levering van eTMF-systemen en technologische dienstverlening.
Phlexglobal Acquires Specialist Software Development Company Net Solutions Europe
AMERSHAM, England and MALVERN, Pa.–(BUSINESS WIRE)– Phlexglobal, pioneers and leaders in the provision of Trial Master File (TMF) technology and services for the global life sciences industry today announces the acquisition of Net Solutions Europe (NSE); an established technology company with a proven track record in delivering superior software solutions, based in the UK.
Phlexglobal has been working in partnership with NSE since 2010 on the development of PhlexEview; its market leading electronic TMF (eTMF) cloud based platform. The acquisition fortifies its position at the forefront of the provision of eTMF solutions and technology enabled services.
Peter McNaney, Phlexglobal chief technology officer said: “As Phlexglobal’s technology partner, NSE has demonstrated a regulatory understanding of the sensitivity of the clinical documents we handle, and their expertise and experience is second to none. We also have appointed an expert eTMF product manager working as part of the newly expanded technology team, and this appointment coupled with the NSE acquisition will further ensure we are at the leading edge of eTMF technology capabilities.”
Rick Riegel, chief executive officer commented: “This acquisition allows us to fast-track the future development of PhlexEview, our cloud based eTMF platform. The resulting enhanced capabilities will provide significant additional benefits to both our software and our services clients.”
Phlexglobal is committed to developing technology solutions for the TMF market to expedite study start up, facilitate regulatory inspection readiness, and improve management and oversight. The technology of choice for over 30 global companies, ranging from top 10 Pharma to biotech and CROs with thousands of worldwide users, a major new release of PhlexEview is anticipated later this year.
For further information please contact: email@example.com
Phlexglobal is a specialist provider of technology-enabled Trial Master File (TMF) solutions and services. Offering a unique combination of clinical trial knowledge, document management skills, regulatory understanding and technical expertise, they deliver a range of flexible, targeted solutions to meet business needs.
Phlexglobal will be exhibiting, presenting and are the sponsors of ExL Pharma’s 5th Trial Master File Summit, taking place on January 20 st – 22 nd 2016 at the Westin Arlington Gateway, VA, US.
Phlexglobal 4th annual US PhlexEview and eTMF User Group Conference from February 29 th – 1 st March 2016 at the Hyatt at the Bellevue, Philadelphia, PA, US.
Phlexglobal 4th annual EU PhlexEview and eTMF User Group Conference from March 14 th – 15 th 2016 at the Hilton London Heathrow Airport, UK.
More information can be found at http://www.phlexglobal.com
Head of Marketing
Tel: +44(0)1494 720420